The 24,000 employee optical and optoelectronic leader from Germany, Carl Zeiss Group has just established its first offshore captive research and development center in India. The center will
- Define products for growth markets like India or China
- Develop new products for these markets, in particular software and solutions that enhance workflow efficiency in doctors’ offices and hospitals
- Develop clinical applications and studies
- Collaborate closely with medial research institutes, hospitals and universities in India in order to jointly develop medical techniques and solutions
Dubbed the Center for Application and Research (CARIn), the India location will focus initially on research in ophthalmology, including glaucoma, cataracts as also diabetes-led eye deficiencies. Over time, according to the company, the R&D activities will be expanded to include the entire product spectrum of Carl Zeiss Meditec. The first employees for the new center have already been recruited. The capacity will be expanded to up to 50 staff in the mid term. “Innovations form the foundation of our strategy that makes the latest medical technology available to high growth markets like India,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec.
